Precision Medicine: Role of Proteomics in Changing Clinical Management and Care

Overview

Journal J Proteome Res

Publisher American Chemical Society

Specialty Biochemistry

Date 2018 Oct 9

PMID 30296097

Citations 19

Authors

Jennifer E Van Eyk

Michael P Snyder

Affiliations

Soon will be listed here.

Abstract

It is now possible to collect large sums of health-related data which has the potential to transform healthcare. Proteomics, with its central position as downstream of genetics and epigenetic inputs and upstream of biochemical outputs and integrators of environmental signals, is well-positioned to contribute to health discoveries and management. We present our perspective on the role of proteomics and other Omics in precision health and medicine.

Citing Articles

Synthetic plasma pool cohort correction for affinity-based proteomics datasets allows multiple study comparison.

Heylen D, Pusparum M, Kuliesius J, Wilson J, Park Y, Jamiolkowski J Brief Bioinform. 2024; 26(1).

PMID: 39694815 PMC: 11653412. DOI: 10.1093/bib/bbae657.

Revolutionizing healthcare and medicine: The impact of modern technologies for a healthier future-A comprehensive review.

Thacharodi A, Singh P, Meenatchi R, Tawfeeq Ahmed Z, Kumar R, V N Health Care Sci. 2024; 3(5):329-349.

PMID: 39479277 PMC: 11520245. DOI: 10.1002/hcs2.115.

Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.

Jaber M, Kahwaji H, Nasr S, Baz R, Kim Y, Fakhoury M Adv Exp Med Biol. 2024; 1456:359-378.

PMID: 39261438 DOI: 10.1007/978-981-97-4402-2_18.

Advances in the Clinical Application of High-throughput Proteomics.

Cui M, Deng F, Disis M, Cheng C, Zhang L Explor Res Hypothesis Med. 2024; 9(3):209-220.

PMID: 39148720 PMC: 11326426. DOI: 10.14218/erhm.2024.00006.

Simultaneous targeted and discovery-driven clinical proteotyping using hybrid-PRM/DIA.

Goetze S, van Drogen A, Albinus J, Fort K, Gandhi T, Robbiani D Clin Proteomics. 2024; 21(1):26.

PMID: 38565978 PMC: 10988896. DOI: 10.1186/s12014-024-09478-5.

References

Ray K, Cannon C, Cairns R, Morrow D, Ridker P, Braunwald E . Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2009; 29(3):424-30. DOI: 10.1161/ATVBAHA.108.181735. View

Fert-Bober J, Murray C, Parker S, Van Eyk J . Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way. Circ Res. 2018; 122(9):1221-1237. PMC: 5963703. DOI: 10.1161/CIRCRESAHA.118.310966. View

Wright I, Van Eyk J . A Roadmap to Successful Clinical Proteomics. Clin Chem. 2016; 63(1):245-247. PMC: 10952121. DOI: 10.1373/clinchem.2016.254664. View

Agger S, Marney L, Hoofnagle A . Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. Clin Chem. 2010; 56(12):1804-13. PMC: 3103773. DOI: 10.1373/clinchem.2010.152264. View

van den Broek I, Nouta J, Razavi M, Yip R, Bladergroen M, Romijn F . Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow. Methods. 2015; 81:74-85. DOI: 10.1016/j.ymeth.2015.03.001. View

Cai W, Tucholski T, Gregorich Z, Ge Y . Top-down Proteomics: Technology Advancements and Applications to Heart Diseases. Expert Rev Proteomics. 2016; 13(8):717-30. PMC: 5026638. DOI: 10.1080/14789450.2016.1209414. View

Zhou H, Hoek M, Yi P, Rohm R, Mahsut A, Brown P . Rapid detection and quantification of apolipoprotein L1 genetic variants and total levels in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2014; 27(23):2639-47. DOI: 10.1002/rcm.6734. View

van den Broek I, Romijn F, Nouta J, van der Laarse A, Drijfhout J, Smit N . Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping. Clin Chem. 2015; 62(1):188-97. DOI: 10.1373/clinchem.2015.246702. View

Ahlqvist E, Storm P, Karajamaki A, Martinell M, Dorkhan M, Carlsson A . Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018; 6(5):361-369. DOI: 10.1016/S2213-8587(18)30051-2. View

10.

Hoofnagle A, Roth M . Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry. J Clin Endocrinol Metab. 2013; 98(4):1343-52. PMC: 3615194. DOI: 10.1210/jc.2012-4172. View

11.

van den Broek I, Fu Q, Kushon S, Kowalski M, Millis K, Percy A . Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers. Clin Mass Spectrom. 2024; 4-5:25-33. PMC: 11322776. DOI: 10.1016/j.clinms.2017.08.004. View

12.

Aebersold R, Agar J, Jonathan Amster I, Baker M, Bertozzi C, Boja E . How many human proteoforms are there?. Nat Chem Biol. 2018; 14(3):206-214. PMC: 5837046. DOI: 10.1038/nchembio.2576. View

13.

Smith L, White M . The role of post-translational modifications in acute and chronic cardiovascular disease. Proteomics Clin Appl. 2014; 8(7-8):506-21. DOI: 10.1002/prca.201400052. View

14.

Cooper A, Ilboudo H, Alibu V, Ravel S, Enyaru J, Weir W . renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife. 2017; 6. PMC: 5495568. DOI: 10.7554/eLife.25461. View

15.

Dayon L, Nunez Galindo A, Corthesy J, Cominetti O, Kussmann M . Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. J Proteome Res. 2014; 13(8):3837-3845. DOI: 10.1021/pr500635f. View

16.

Whiteaker J, Zhao L, Anderson L, Paulovich A . An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics. 2009; 9(1):184-96. PMC: 2808264. DOI: 10.1074/mcp.M900254-MCP200. View

17.

Limou S, Nelson G, Kopp J, Winkler C . APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis. 2014; 21(5):426-33. PMC: 4157456. DOI: 10.1053/j.ackd.2014.06.005. View

18.

Menon R, Im H, Zhang E, Wu S, Chen R, Snyder M . Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes. J Proteome Res. 2013; 13(1):212-27. PMC: 3943430. DOI: 10.1021/pr400773v. View

19.

Chen R, Mias G, Li-Pook-Than J, Jiang L, Lam H, Chen R . Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012; 148(6):1293-307. PMC: 3341616. DOI: 10.1016/j.cell.2012.02.009. View

20.

Li X, Dunn J, Salins D, Zhou G, Zhou W, Schussler-Fiorenza Rose S . Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information. PLoS Biol. 2017; 15(1):e2001402. PMC: 5230763. DOI: 10.1371/journal.pbio.2001402. View